Improving Sleep Quality in Heart Failure
Completed · Phase 4 · Has a placebo group
Conditions studied: Sleep Disturbance, Heart Failure
In brief
Poor sleep quality is common in patients with heart failure. The limited available evidence intimates that improving sleep quality in patients with heart failure may improve morbidity and quality of life in this patient population. However, there is a paucity of evidence assessing the use of effective pharmacologic therapies in heart failure. The nonbenzodiazepine, GABA receptor agonist, zolpidem, has been found to have considerable benefits over traditional benzodiazepines as a soporific medication. The investigators hypothesize that zolpidem will safely improve sleep quality in patients with heart failure.
Key facts
- Study ID
- NCT03307005
- Run by
- Johns Hopkins University
- People needed
- 5
- Starts
- 2017-11-01
- Expected to finish
- 2019-01-25
- Last updated by the study team
- 2020-02-11
Who can join
Age: 21 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 21-79 years old
- HFrEF, EF ≤ 45% (by echocardiography)
- NYHA functional class I to III
- Able to give written consent
- On goal-directed medical therapy for HF, with stable dosing of HF medications for 2 weeks prior to enrollment
- No hospitalizations for HF within the past month
- Positive response to experiencing any of the following sleep-related symptoms at least once a week:
- Difficulty falling asleep
- Waking up during the night and having difficulty getting back to sleep
- Waking up too early in the morning and being unable to get back to sleep.
You may not qualify if…
- Use of sedative-hypnotics, anxiolytic, or benzodiazepines within the previous 2 weeks
- Current treatment with other sedating medications such as opioids
- On therapy for pharmacological therapy for depression
- History of alcohol/drug dependence
- History of liver disease, HIV, or severe COPD
- On Thorazine
- Current use of ketoconazole
- Current use of tricyclic antidepressants
- Current use of macrolide antibiotics
- Current use of anticonvulsant medications
- Pregnancy. A urine pregnancy test will be performed to exclude pregnancy in potential subjects.
Where it is running
- Johns Hopkins Bayview Campus, Asthma and Allergy Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.